Results 91 to 100 of about 18,801 (261)

Fractional exhaled nitric oxide in monitoring and therapeutic management of asthma [PDF]

open access: yes, 2014
INTRODUCTION: Asthma is a chronic respiratory disease characterized by hyper-responsiveness and bronchial inflammation. The bronchial inflammation in these patients can be monitored by measuring the fractional exhaled nitric oxide.
Moreira, C   +6 more
core  

Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity

open access: yesAllergy, EarlyView.
Adipokine secretion from adipose tissue may be involved in obesity‐related asthma, but it is unknown how adipokine levels relate to asthma characteristics. Plasma adipokines were measured in well‐characterized lean, overweight or obese patients with mild‐to‐moderate or severe asthma.
Lars I. Andersson   +20 more
wiley   +1 more source

Fractional exhaled nitric oxide over time in L-arginine and L-arginine-placebo study arms.

open access: yes, 2013
Fractional exhaled nitric oxide over time in L-arginine and L-arginine-placebo study arms.
Tsin W. Yeo (218400)   +18 more
core   +1 more source

Exhaled biomarkers in childhood asthma: old and new approaches

open access: yesAsthma Research and Practice, 2018
Background Asthma is a chronic condition usually characterized by underlying inflammation. The study of asthmatic inflammation is of the utmost importance for both diagnostic and monitoring purposes.
Valentina Ferraro   +4 more
doaj   +1 more source

Type‐2‐Inflammatory‐Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 Blockade

open access: yesAllergy, EarlyView.
Studies suggest that type 2 inflammatory diseases are driven by overactivation of the IL4/IL13 pathway, manifesting differently in distinct tissues. We performed quantitative analyses using several large independent datasets to explore the interrelation of type 2 inflammatory diseases based on co‐prevalence, genetic predispositions, and transcriptomic ...
Jennifer D. Hamilton   +19 more
wiley   +1 more source

Between-occasion repeatability of fractional exhaled nitric oxide measurements in children

open access: yesJornal Brasileiro de Pneumologia
The aim of the study was to assess short-term repeatability of measurements of fractional exhaled nitric oxide (FENO) and its correlates in children in the 6- to 9-year age bracket participating in a respiratory epidemiological survey.
Kamil Barański, Jan E. Zejda
doaj   +1 more source

The effects of fine particulate matter constituents on exhaled nitric oxide and DNA methylation in the arginase–nitric oxide synthase pathway

open access: yesEnvironment International, 2019
Background: Fine particulate matter (PM2.5) has been widely associated with airway inflammation represented by increased fractional concentration of exhaled nitric oxide (FeNO).
Qingli Zhang   +14 more
doaj   +1 more source

Adiposity, Fractional Exhaled Nitric Oxide, and Asthma in U.S. Children [PDF]

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2014
Abstract Rationale Whether allergic airway inflammation mediates the association between overweight or obesity and childhood asthma is unknown. Objectives To examine adiposity, asthma, and fractional exhaled nitric ...
Yueh-Ying, Han   +2 more
openaire   +2 more sources

Early Intervention With Biologics for Asthma Remission: Promising or Premature?

open access: yes
Respirology, EarlyView.
Santi Nolasco   +2 more
wiley   +1 more source

Is Asthma Remission a New Achievable Goal? A Review of the Current Drug‐Related Evidence and Predictors

open access: yesAllergy, EarlyView.
ABSTRACT Advances in asthma therapies have shown that clinical remission may be an achievable therapeutic goal for patients with asthma. This review discusses the current definitions of remission in asthma, the predictors of remission, airway inflammation/epithelial damage in asthma remission, airway remodeling, paradigms in defining remission and ...
Fatma Esra Gunaydin   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy